Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin

Ivana Turek

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (44)

  1. "Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli". 2023-08-01 · Expand citations
  2. Australia to prescribe MDMA and psilocybin for PTSD and depression in world first. 2023-07-01 · Expand citations
  3. How ecstasy and psilocybin are shaking up psychiatry. 2021-01-01 · Expand citations
  4. Development of an improved psilocybin synthesis 2019-12-31 · Expand citations
  5. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  6. Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. 2004-03-01 · Expand citations
  7. The pharmacology of psilocybin. 2002-10-01 · Expand citations
  8. Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. 1999-06-01 · Expand citations
  9. [Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim]. 1958-03-15 · Expand citations
  10. OpenAlex W1962052985
  11. OpenAlex W2006895664
  12. OpenAlex W2141209126
  13. OpenAlex W2148841660
  14. OpenAlex W2154191181
  15. OpenAlex W2157305173
  16. OpenAlex W2199093360
  17. OpenAlex W2282484587
  18. OpenAlex W2494477347
  19. OpenAlex W2547881037
  20. OpenAlex W2616653812
  21. OpenAlex W2756282134
  22. OpenAlex W2905689668
  23. OpenAlex W2916674868
  24. OpenAlex W2917202476
  25. OpenAlex W3014627976
  26. OpenAlex W3099423662
  27. OpenAlex W3111428945
  28. OpenAlex W3139079540
  29. OpenAlex W3142425130
  30. OpenAlex W3152710445
  31. OpenAlex W3157866107
  32. OpenAlex W4211238337
  33. OpenAlex W4212985029
  34. OpenAlex W4221049236
  35. OpenAlex W4221098483
  36. OpenAlex W4224046478
  37. OpenAlex W4241030589
  38. OpenAlex W4281482740
  39. OpenAlex W4295073950
  40. OpenAlex W4312558268
  41. OpenAlex W4366421959
  42. OpenAlex W4368362129
  43. OpenAlex W4378902070
  44. OpenAlex W4385901848

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.